Sunshine Biopharma, Inc. (SBFM)
1.13
-0.04
(-3.42%)
USD |
NASDAQ |
Sep 03, 13:27
Sunshine Biopharma 1 Year Total Returns (Daily) : -91.88% for Sept. 2, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 02, 2026 | -91.88% |
| September 01, 2026 | -92.15% |
| August 31, 2026 | -92.22% |
| August 28, 2026 | -92.28% |
| August 27, 2026 | -91.42% |
| August 26, 2026 | -91.45% |
| August 25, 2026 | -91.86% |
| August 24, 2026 | -91.71% |
| August 21, 2026 | -91.83% |
| August 20, 2026 | -91.88% |
| August 19, 2026 | -91.76% |
| August 18, 2026 | -92.38% |
| August 17, 2026 | -92.48% |
| August 14, 2026 | -92.38% |
| August 13, 2026 | -92.00% |
| August 12, 2026 | -91.48% |
| August 11, 2026 | -91.40% |
| August 10, 2026 | -91.29% |
| August 07, 2026 | -91.21% |
| August 06, 2026 | -90.00% |
| August 05, 2026 | -90.70% |
| August 04, 2026 | -91.03% |
| August 03, 2026 | -91.70% |
| July 31, 2026 | -91.88% |
| July 30, 2026 | -91.63% |
| Date | Value |
|---|---|
| July 29, 2026 | -91.85% |
| July 28, 2026 | -90.59% |
| July 27, 2026 | -90.25% |
| July 24, 2026 | -89.29% |
| July 23, 2026 | -89.18% |
| July 22, 2026 | -88.62% |
| July 21, 2026 | -88.78% |
| July 20, 2026 | -88.91% |
| July 17, 2026 | -88.75% |
| July 16, 2026 | -87.96% |
| July 15, 2026 | -87.67% |
| July 14, 2026 | -87.11% |
| July 13, 2026 | -87.34% |
| July 10, 2026 | -86.90% |
| July 09, 2026 | -86.28% |
| July 08, 2026 | -86.05% |
| July 07, 2026 | -85.85% |
| July 06, 2026 | -85.94% |
| July 02, 2026 | -87.21% |
| July 01, 2026 | -84.97% |
| June 30, 2026 | -85.42% |
| June 29, 2026 | -85.55% |
| June 26, 2026 | -85.17% |
| June 25, 2026 | -84.82% |
| June 24, 2026 | -86.31% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 12.61% |
| Alnylam Pharmaceuticals, Inc. | -40.18% |
| Anika Therapeutics, Inc. | 135.5% |
| Savara, Inc. | 64.95% |
| Vericel Corp. | 18.18% |